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Background
Recent data support a prominent role for B cells in MS
physiopathology. Recently it has emerged that subsets of B
cells secreting IL-10 negatively regulate disease symptoms
in Experimental Autoimmune Encephalomyelitis (EAE).
However, the involvement of such regulatory B cells in
MS remains unclear.
Aim
We aimed to study the frequency, phenotype and func-
tion of regulatory B cells in MS patients as compared to
Healthy Volunteers (HV).
Methods
Sixty-three untreated MS patients and 58 HV were
included in this study. IL-10 secretion by B cells and phe-
notype of IL-10+ B cells were studied after 5h (B10 cells)
and 48h of stimulation (B10pro cells) by CD40L and
ODN. Coculture assays with prestimulated B cells and
responding CD4+CD25- T cells were performed for 3 days.
Results
No significant difference was found either for IL-10 secre-
tion ability of B cells after 5h or 48h of stimulation. The
analysis of B10pro cells phenotype revealed mainly a
memory phenotype in MS and HV, even if both naïve and
immature subsets were also able to secrete IL-10. Presti-
mulated B cells from MS inhibited CD4+CD25- T cell pro-
liferation in the same manner than HV by a contact
dependent mechanism, independently of IL-10 and TGF-b
secretion.
Conclusion
Altogether, our data show that regulatory B cells have a
conserved frequency, phenotype and function in the
blood of patients with MS suggesting that B cells do not
contribute to the physiopathology of the disease.
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